Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Khanjan Nagarsheth

Vascular Surgery Baltimore, MD Medical Doctor

NPI 1275789430 CMS profile 3866691

419 W Redwood St Ste 240, Baltimore, MD 21201

Open in the dashboard

General payments

$33,080

353 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$361,903 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Khanjan Nagarsheth of Baltimore, MD is reported in the CMS Open Payments database as having received $33,080 across 353 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $361,903 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,524 66
2024 General $4,999 51
2023 General $1,954 38
2022 General $3,590 56
2021 General $828 24
2020 General $4,799 39
2019 General $7,386 79

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Khanjan Nagarsheth
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Khanjan Nagarsheth were reported at $9,524. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Khanjan Nagarsheth Vascular Surgery median Middle half National median
2019 $7,386 $796 $226–$2,363 $163
2020 $4,799 $348 $118–$1,110 $114
2021 $828 $471 $158–$1,421 $132
2022 $3,590 $725 $222–$2,183 $149
2023 $1,954 $836 $257–$2,440 $160
2024 $4,999 $909 $252–$2,619 $164
2025 $9,524 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $7,487 32 payments
  2. Inari Medical, Inc. $4,741 24 payments
  3. Medtronic Vascular, Inc. $2,544 5 payments
  4. Boston Scientific Corporation $2,452 24 payments
  5. Endologix, Inc. $2,393 15 payments
  6. Abbott Laboratories $1,714 13 payments
  7. W. L. Gore & Associates, Inc. $1,709 25 payments
  8. Silk Road Medical, Inc. $1,697 17 payments
  9. Smith+Nephew, Inc. $1,672 62 payments
  10. Cook Medical LLC $1,114 21 payments
  11. Other $5,558 115 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $18,345 315 payments
  2. Travel and Lodging $10,992 35 payments
  3. Grant $2,500 1 payment
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,200 1 payment
  5. Entertainment $43 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $4,806 25 payments
  2. CT THROMBECTOMY SYSTEM KIT $4,675 23 payments
  3. Indigo $4,347 16 payments
  4. Indigo System $3,547 14 payments
  5. Endurant $2,528 2 payments
  6. ENROUTE 0.014 Guidewire $1,368 10 payments
  7. ENROUTE Transcarotid Stent System $1,368 10 payments
  8. ENROUTE Transcarotid Neuroprotection System $1,368 10 payments
  9. ENHANCE Transcarotid Peripheral Access Kit $1,368 10 payments
  10. Omnilink Elite vascular stent system $1,200 1 payment
  11. Other $21,204 428 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

38

Median for Vascular Surgery: 122

Drug cost

$268

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 38 $268

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 181 billing codes

Paid by Medicare

$471,562

Medicare's payments for the services billed

Medicare patients

537

Average age 72

Services billed

1,483

261 women, 276 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 53%
Ischemic heart disease 53%
Arthritis 50%
Chronic kidney disease 44%
Heart failure 35%
Atrial fibrillation 30%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

353 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record